Vascular endothelial growth factor corrected for platelet count and hematocrit is associated with the clinical course of aplastic anemia in children
International Journal of Hematology, 05/02/2012Kodama Y et al.
The data indicate that a compensatory mechanism for increasing vascular endothelial growth factor (VEGF) and preventing disease progression might play a role in aplastic anemia (AA). Corrected VEGF may be useful for predicting the clinical course of AA.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.